发明名称 |
Pharmaceutical control of inflammation |
摘要 |
Control of inflammation is achieved by control of the level and/or activity of the enzyme heme-oxygenase (HO). A HO inducer is anti-inflammatory (figure 14) and used to treat inflammation, such as chronic inflammatory diseases. A HO inhibitor promotes inflammation and is used to treat immunosuppressed conditions. Alternative, or additional, control of heme-oxygenase activity is achieved by control of nitric oxide levels, elevated levels promoting inflammation. |
申请公布号 |
AU3528195(A) |
申请公布日期 |
1996.04.09 |
申请号 |
AU19950035281 |
申请日期 |
1995.09.22 |
申请人 |
THE WILLIAM HARVEY RESEARCH INSTITUTE |
发明人 |
DEAN WILLIS;ADRIAN RICHARD MOORE;DEREK ALBERT WILLOUGHBY |
分类号 |
A61K9/06;A61K9/08;A61K31/00;A61K31/195;A61K31/40;A61K31/55;A61K31/557;A61K33/26;A61K45/00;A61P1/00;A61P11/00;A61P11/08;A61P25/00;A61P29/00;A61P37/00 |
主分类号 |
A61K9/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|